0571-26280011

epi@eastpoint.com.cn

CN EN
About Us
Drawing on the unique characteristics of our customers' medical device products, we offer a tailored and personalized integrated service model that spans from preclinical to clinical research and registration consultation. Our aim is to provide comprehensive support throughout the product development lifecycle, ensuring the delivery of essential preclinical research data, conducting rigorous clinical research, and facilitating seamless registration declaration processes.
Business
Drawing on the unique characteristics of our customers' medical device products, we offer a tailored and personalized integrated service model that spans from preclinical to clinical research and registration consultation. Our aim is to provide comprehensive support throughout the product development lifecycle, ensuring the delivery of essential preclinical research data, conducting rigorous clinical research, and facilitating seamless registration declaration processes.
Business Acceptance

Business Acceptance

Drawing on the unique characteristics of our customers' medical device products, we offer a tailored and personalized integrated service model that spans from preclinical to clinical research and registration consultation. Our aim is to provide comprehensive support throughout the product development lifecycle, ensuring the delivery of essential preclinical research data, conducting rigorous clinical research.
News Center
To best serve our customers' needs, we offer a personalized integrated service model tailored to the characteristics of their medical device products. This model encompasses a comprehensive range of services from preclinical to clinical research and registration consultation, ensuring the provision of essential preclinical research data, conducting robust clinical research, and facilitating seamless registration declaration processes.
Team Introduction
Based on the unique features of the customer's medical device products, we tailor a personalized integrated service model spanning from preclinical to clinical research and registration consultation. This enables us to better assist customers by providing comprehensive support, including basic preclinical research data, clinical research, and assistance with registration declaration for the product.

Chuangxiang Reception Hall Enters EastPoint Innovation

2023年12月01日

On the afternoon of November 30, 2023, the Chuangxiang Reception Hall welcomed the East Point Medical Event, hosting a successful sharing and exchange session focused on the theme of "Standardized Operation of Preclinical Large Animal Experiments for Medical Devices" in the training conference room on the second floor. Representatives from biopharmaceutical-related enterprises in Linping District were in attendance.


4-1.jpg


The event commenced with a brief introduction by Teacher Zhang from the Linping District Biomedical Association, outlining the organizing philosophy and acknowledging the guests. Gratitude was expressed to the event organizer, East Point Medical.


4-2.jpg


The training session was led by Shao Mingyue, Deputy General Manager of East Point Medical, and Zhao Jinchuan, Head of the Safety Evaluation Department, who delivered insightful presentations on "preclinical animal experiments" and "biological evaluation." Following the lectures, guests engaged in discussions and exchanged ideas with the speakers. Subsequently, attendees were guided on a tour of the high-end operating rooms at East Point Medical, including the Interventional Catheter Room and CT Room. The laboratory's advanced software and hardware capabilities were highly praised by the visiting representatives.


4-3.jpg


Through this collaborative sharing and exchange, attendees gained deeper insights into large animal experiments and biological evaluations of medical devices, expressing optimism for future cooperation.

As the vice president of the Linping District Biomedical Association, East Point Medical reaffirms its commitment to serving enterprises in the region and contributing to the continued development of the biopharmaceutical industry in Linping District.